Adequate Dairy Intake on Weight Change in Girls (DQ)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01066806|
Recruitment Status : Completed
First Posted : February 10, 2010
Last Update Posted : September 22, 2016
SPECIFIC AIM The aim of this study is to determine if increasing calcium intake to recommended levels with dairy foods in adolescent females with habitually low calcium intake and above-the-median body mass index (BMI) for sex and age will decrease body fat gain compared to similar females who continue their low calcium intake. .
HYPOTHESIS Post-menarcheal adolescent girls with habitually low calcium intake who consume dairy foods providing at least 1200 mg of calcium per day will have a smaller increase in percent body fat, as measured by dual energy absorptiometry, during one year than post-menarcheal adolescent girls on a usual diet of 600 mg of calcium per day or less.
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Behavioral: counseling on increasing calcium intake Other: observation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||274 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Efficacy of Optimal Levels of Dietary Dairy on Modulation of Adolescent Weight|
|Study Start Date :||July 2008|
|Actual Primary Completion Date :||September 2013|
|Actual Study Completion Date :||September 2013|
|Experimental: high calcium diet||
Behavioral: counseling on increasing calcium intake
The American Academy of Pediatrics recommends that adolescents ingest at least four servings of dairy food and at least 1300 mg calcium per day.
|Active Comparator: normal calcium diet||
observe normal dairy intake
- percent change in body fat [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01066806
|United States, Nebraska|
|Creighton University Medical Center, Osteoporosis Research Center|
|Omaha, Nebraska, United States, 68131|
|Principal Investigator:||Joan M Lappe, PhD||Creighton University, Osteoporosis Research Center|